Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
    • Articles
  • Pipeline
    • Overview
    • MT-6402
    • MT-5111
    • MT-0169
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Molecular Templates to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Jul 06, 2021 8:00am EDT

Molecular Templates, Inc. Reports First Quarter 2021 Financial Results

May 13, 2021 4:30pm EDT

Molecular Templates Announces Poster Presentations on its Engineered Toxin Bodies at the American Association of Cancer Research (AACR) Virtual Annual Meeting I

Apr 12, 2021 7:00am EDT

Molecular Templates to Prioritize Next-Generation ETB Candidates

Apr 05, 2021 7:00am EDT

Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results

Mar 18, 2021 4:30pm EDT

Molecular Templates to Participate in Upcoming Virtual Investor Conferences

Feb 26, 2021 8:00am EST

Molecular Templates, Inc. Announces Pricing of $75.9 Million Public Equity Offering

Feb 18, 2021 7:30am EST

Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock

Feb 17, 2021 4:05pm EST

Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

Feb 11, 2021 7:30am EST

Molecular Templates Announces FDA Acceptance of IND Application for MT-6402, a PD-L1-Targeted Engineered Toxin Body Enabled with Proprietary Antigen Seeding Technology

Jan 19, 2021 8:00am EST
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12
    Next
    © 2023 Molecular Templates, Inc. All Rights Reserved.
    Twitter Linkedin
    Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access